evaluation of an ITM – based protocol on clinical improvement of CVA
- Conditions
- Ischemic cerebro vascular attack.cerebro vascular syndromG46.4*
- Registration Number
- IRCT2015122025622N1
- Lead Sponsor
- Vice chancellor for research,Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
In our study, the inclusion criteria encompassed patients whom were discovered to have focal neurological symptoms after their brain imaging, being diagnosed with ischemic CVA.
On the other hand, the exclusion criteria were as follows: 1. patients with focal neurological findings ith regard to the candidate symptoms of venous rTPA; 2. patients with symptoms in less than 24 hours of a TIA with normal imaging raises; 3. patients on admission with NIHSS Score and analytically based on a bad prognosis. 4. patients with chronic systemic diseases such as uremia, chronic liver disease, and high blood pressure a potential impact would be on our protocol and our intervention would accelerate HIV disease; 6. patients with possible teratogenic effects of safflower pregnancy; 7. patients having any evidence of brain hemorrhage; 8. patients receiving anticoagulant (heparin or warfarin); 9. incidence of venous infarcts in venous sinus thrombosis; 10. patients reluctant to continue double-blind treatment. During hospitalization, the patients were visited on a daily basis by experts who closely supervised the treatment.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score of disability based on Questionnaire NIHSS. Timepoint: Baseline and one month after presentation. Method of measurement: Clinical examination by an expert on the NIHSS score.
- Secondary Outcome Measures
Name Time Method Biochemical markers. Timepoint: Baseline and one month after the initial visit. Method of measurement: blood test.